[1] Kabiri A1, Esfandiari E2, Esmaeili A, et al. Platelet-rich plasma application in chondrogenesis. Adv Biomed Res, 2014, 3∶138 [2] 吴小兵, 董小岩, 伍志坚,等.一种快速高效分离和纯化重组腺病毒伴随病毒载体的方法. 科学通报, 2000, 45(19)∶2071-2075 [3] Tabbaa SM1, Horton CO1, Jeray KJ2, et al. Role of vascularity for successful bone formation and repair. Crit Rev Biomed Eng, 2014, 42(3-4)∶319-348 [4] Naganawa T, Xiao L, Coffin JD, et al. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem, 2008,103 (6)∶1975-1988 [5] Agata H, Asahina I, Yamazaki Y, et al. Effective bone engineering with periosteum-derived cells. J Dent Res, 2007, 86(1)∶79-83 [6] Walsh S, Jefferiss C, Stewart K, et al. Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone, 2000, 27(2)∶185-195 [7] Zhang X, Sobue T, Hurley MM. FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem Biophys Res Commun, 2002, 290(1)∶526-531 [8] Springer IN, Niehoff P, Acil Y, et al. BMP-2 and bFGF in an irradiated bone model. J Craniomaxillofac Surg, 2008, 36(4)∶210-217 [9] Sriram M1, Sainitya R1, Kalyanaraman V,et al. Biomaterials mediated microRNA delivery for bone tissue engineering.Int J Biol Macromol, 2015, 74∶404-412 [10] Fernandez-Yague MA1, Abbah SA1, McNamara L, et al. Biomimetic approaches in bone tissue engineering: Integrating biological and physicomechanical strategies.Adv Drug Deliv Rev, 2015, 84∶1-29 [11] Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A, 1992, 89(12)∶5547-4451 [12] Freundlieb S, Schirra-Muller C, Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med, 1999, 1(1)∶4-12 [13] Cao M, Theus SA, Straub KD, et al. AAV2/8-humanFOXP3 gene therapy shows robust anti-atherosclerosis efficacy in LDLR-KO mice on high cholesterol diet. J Transl Med, 2015, 13(1)∶235 [14] Nussinovitch U, Gepstein L. Optogenetics for in vivo cardiac pacing and resynchronization therapies. Nat Biotechnol, 2015, 33(7)∶750-754 [15] Weger S1, Hammer E2, Heilbronn R, et al. Differential contribution of adeno-associated virus type 2 Rep protein expression and nucleic acid elements to inhibition of adenoviral replication in cis and in trans. J Virol, 2014, 88(24)∶14126-14137 |